Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer

Gynecologic Oncology

Volumn 138, Issue 2, 2015, Pages 332-338

  Matsuo, Koji ^a,b   Hom, Marianne S ^c   Moeini, Aida ^a   Machida, Hiroko ^a   Takeshima, Nobuhiro ^d   Roman, Lynda D ^a   Sood, Anil K ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d CANCER INSTITUTE HOSPITAL   (Japan)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Endometrial cancer; Monocyte; Survival outcome

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN;

ADULT; ARTICLE; BASOPHIL COUNT; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HISTOLOGY; HUMAN; HYSTERECTOMY; LEUKOCYTE COUNT; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MIDDLE AGED; MONOCYTE; MONOCYTE COUNT; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIC LYMPH NODE METASTASIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL PREDICTION; SURVIVAL RATE; THROMBOCYTE COUNT; TUMOR INVASION; AGED; BLOOD; ENDOMETRIAL NEOPLASMS; MACROPHAGE; MONOCYTE MACROPHAGE PRECURSOR CELL; PATHOLOGY; PROGNOSIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MACROPHAGES; MIDDLE AGED; MONOCYTE-MACROPHAGE PRECURSOR CELLS; MONOCYTES; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84938197638     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.05.019     Document Type: Article

References (34)

1. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J. Clin. 65 1 Jan-Feb 2015 5 29
2. J.D. Wright, N.I. Barrena Medel, J. Sehouli, K. Fujiwara, and T.J. Herzog Contemporary management of endometrial cancer Lancet 379 9823 Apr 7 2012 1352 1360
3. O.J. Finn Cancer immunology N. Engl. J. Med. 358 25 Jun 19 2008 2704 2715
4. E. Zsiros, and K. Odunsi Tumor-associated macrophages: co-conspirators and orchestrators of immune suppression in endometrial adenocarcinoma Gynecol. Oncol. 135 2 Nov 2014 173 175
5. S. Ohno, Y. Ohno, N. Suzuki, T. Kamei, K. Koike, H. Inagawa, and et al. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer Anticancer Res. 24 5C Sep-Oct 2004 3335 3342
6. S. Soeda, N. Nakamura, T. Ozeki, H. Nishiyama, H. Hojo, H. Yamada, and et al. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma Gynecol. Oncol. 109 1 Apr 2008 122 128
7. R.A. de Jong, N. Leffers, H.M. Boezen, K.A. ten Hoor, A.G. van der Zee, H. Hollema, and et al. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer Gynecol. Oncol. 114 1 Jul 2009 105 110
8. I. Espinosa, M. Jose Carnicer, L. Catasus, B. Canet, E. D'Angelo, G.F. Zannoni, and et al. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role Am. J. Surg. Pathol. 34 11 Nov 2010 1708 1714
9. X.F. Jiang, Q.L. Tang, H.G. Li, X.M. Shen, X. Luo, X.Y. Wang, and et al. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma J. Obstet. Gynaecol. Res. 39 4 Apr 2012 855 863
10. K. Kubler, T.H. Ayub, S.K. Weber, O. Zivanovic, A. Abramian, M.D. Keyver-Paik, and et al. Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma Gynecol. Oncol. 135 2 Nov 2014 176 183
11. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J. Clin. Invest. 122 3 Mar 2012 787 795
12. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol. 23 11 Nov 2002 549 555
13. A. Mantovani, and P. Allavena The interaction of anticancer therapies with tumor-associated macrophages J. Exp. Med. 212 4 Apr 6 2015 435 445
14. R. Noy, and J.W. Pollard Tumor-associated macrophages: from mechanisms to therapy Immunity 41 1 Jul 17 2014 49 61
15. J. Condeelis, and J.W. Pollard Macrophages: obligate partners for tumor cell migration, invasion, and metastasis Cell 124 2 Jan 27 2006 263 266
16. STROBE guideline at http://www.strobe-statement.org/.
17. K. Matsuo, S.S. Cahoon, M. Gualtieri, C.A. Scannell, C.E. Jung, T. Takano, and et al. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer Ann. Surg. Oncol. 21 13 Dec 2014 4246 4255
18. K. Matsuo, M.J. Gray, D.Y. Yang, S.A. Srivastava, P.B. Tripathi, L.A. Sonoda, and et al. The endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survival Gynecol. Oncol. 128 3 Mar 2013 552 559
19. K. Matsuo, N.R. Opper, M.A. Ciccone, J. Garcia, K.E. Tierney, T. Baba, and et al. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome Obstet. Gynecol. 125 Feb 2015 424 433
20. K. Matsuo, A.A. Yessaian, Y.G. Lin, H.Q. Pham, L.I. Muderspach, H.A. Liebman, and et al. Predictive model of venous thromboembolism in endometrial cancer Gynecol. Oncol. 128 3 Mar 2013 544 551
21. R. Takahashi, S. Mabuchi, M. Kawano, T. Sasano, Y. Matsumoto, H. Kuroda, and et al. Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: A monoinstitutional study Gynecol. Oncol. 137 Apr 2015 112 118
22. T.S. Njolstad, H. Engerud, H.M. Werner, H.B. Salvesen, and J. Trovik Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas Gynecol. Oncol. 131 2 Nov 2013 410 415
23. J.K. Chan, D.S. Kapp, M.K. Cheung, K. Osann, J.Y. Shin, D. Cohn, and et al. The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients Br. J. Cancer 97 5 Sep 3 2007 605 611
24. S. Pecorelli Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int. J. Gynaecol. Obstet. 105 2 May 2009 103 104
25. N. Brooks, L. Stojanovska, P. Grant, V. Apostolopoulos, C.F. McDonald, and D.S. Pouniotis Characterization of blood monocyte phenotype in patients with endometrial cancer Int. J. Gynecol. Cancer 22 9 Nov 2012 1500 1508
26. B.W. Kim, Y.E. Jeon, H. Cho, E.J. Nam, S.W. Kim, S. Kim, and et al. Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte J. Obstet. Gynaecol. Res. 38 1 Jan 2012 48 56
27. G.N. Armaiz-Pena, V. Gonzalez-Villasana, A.S. Nagaraja, C. Rodriguez-Aguayo, N.C. Sadaoui, R.L. Stone, and et al. Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth Oncotarget 6 6 Feb 28 2015 4266 4273
28. Y.Y. Lee, C.H. Choi, C.O. Sung, I.G. Do, S. Huh, T. Song, and et al. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level Gynecol. Oncol. 124 1 Jan 2012 92 97
29. M.J. Worley Jr., C.C. Nitschmann, M. Shoni, A.F. Vitonis, J.A. Rauh-Hain, and C.M. Feltmate The significance of preoperative leukocytosis in endometrial carcinoma Gynecol. Oncol. 125 3 Jun 2012 561 565
30. M.Z. Noman, G. Desantis, B. Janji, M. Hasmim, S. Karray, P. Dessen, and et al. PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation J. Exp. Med. 211 5 May 5 2014 781 790
31. A.S. Neill, C.M. Nagle, M.M. Protani, A. Obermair, A.B. Spurdle, and P.M. Webb Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: A case-control study, systematic review and meta-analysis Int. J. Cancer 132 2013 1146 1155
32. A. Ribas Tumor immunotherapy directed at PD-1 N. Engl. J. Med. 366 2012 2517 2519
33. T.L. Rogers, and I. Holen Tumour macrophages as potential targets of bisphosphonates J. Transl. Med. 9 2011 177
34. N. Gronich, and G. Rennert Beyond aspirin - cancer prevention with statins, metformin and bisphosphonates Nat. Rev. Clin. Oncol. 10 11 Nov 2013 625 642